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CONGENITAL HEART DISEASE
Pericardial effusion after open heart surgery for
congenital heart disease
E W Y Cheung, S A Ho, K K Y Tang, A K T Chau, C S W Chiu, Y F Cheung
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Heart 2003;89:780–783
Objectives: To determine the prevalence and time course of pericardial effusion after open heart sur-
gery for congenital heart diseases and to identify predisposing risk factors.
Design and patients: Prospective assessment of development of pericardial effusion in 336 patients
(163 males) undergoing open heart surgery for congenital heart disease by serial echocardiography
on days 5, 7, 14, 21, and 28 postoperatively.
Setting: Tertiary paediatric cardiac centre.
Results: The prevalence of pericardial effusion was 23% (77 of 336). Of the 77 patients who devel-
oped effusion, 43 (56%) had moderate to large effusions and 18 (23%) were symptomatic. Patients
who had a large amount of effusion were more likely to be symptomatic than those with only a small
to moderate amount (47.4% v 15.5%, p = 0.01). The mean (SD) onset of pericardial effusion was 11
(7) days after surgery, with 97% (75 of 77) of cases being diagnosed on or before day 28 after sur-
gery. The prevalence of effusion after Fontan-type procedures (60%, 6 of 10) was significantly higher
than that after other types of cardiac surgery: repair of left to right shunts (22.1%, 43 of 195), repair
of lesions with right ventricular outflow tract obstruction (22.6%, 19 of 84), arterial switch operation
(6.7%, 1 of 15), and miscellaneous procedures (25%, 8 of 32) (p = 0.037). Univariate analyses
showed that female patients (p = 0.009) and those receiving warfarin (p = 0.002) had increased risk
of postoperative pericardial effusion. A greater pericardial drain output in the first four hours after sur-
gery also tended to be significant (p = 0.056). Multivariate logistic regression similarly identified war-
farin treatment (β = 1.73, p = 0.009) and female sex (β for male = −0.63, p = 0.037) as significant
determinants.
Conclusions: Pericardial effusion occurs commonly after open heart surgery for congenital heart dis-
ease. Serial echocardiographic monitoring up to 28 days postoperatively is indicated in selected high
risk patients such as those with symptoms of postpericardiotomy syndrome and those given warfarin.
Pericardial effusion occurs commonly after open heart sur-gery and contributes to postoperative morbidity andmortality.1–5 Nonetheless, data on its prevalence and time
course after surgery for congenital heart disease are
limited.6 7 Furthermore, risk factors that predispose to its
development in children and teenagers with congenital heart
disease after undergoing open heart surgery remain un-
known. In this study, we sought to determine the prevalence
and time course of pericardial effusion after different types of
open heart surgery for congenital heart disease and, in light of
the findings, to identify significant predisposing risk factors.
PATIENTS AND METHODS
A total of 359 children and teenagers who underwent open
heart surgery for congenital heart disease between 1996 and
2001 were recruited. Serial two dimensional echocardiography
was performed on days 5, 7, 14, 21, and 28 postoperatively
using a Hewlett-Packard ultrasound machine (Sonos 1500 or
5500) to assess development of pericardial effusion. Pericar-
dial effusion was assessed in the standard parasternal short
axis, long axis, apical four chamber, and subcostal views. The
amount of pericardial effusion was graded according to the
ratio of maximum separation between pericardium and
epicardium at diastole to aortic root size as small (< 0.33),
moderate (> 0.33 to< 0.67,) or large (> 0.67). The location of
the perfusion was described as circumferential or loculated.
The following data were collected: demographic data,
cardiac diagnoses, types of surgery performed, pericardial
drain output within the first 48 hours of operation,
reoperation for haemostasis, timing of pericardial drain
removal, postoperative use of anticoagulant and diuretics, and
occurrence of pericardial effusion. In patients who developed
pericardial effusion, the timing of onset and duration of effu-
sion, their clinical presentation, and the treatments received
were noted.
Data are expressed as mean (SD) unless otherwise stated.
The demographic, clinical, and perioperative variables be-
tween patients who developed pericardial effusion and those
who did not were compared using unpaired Student’s t test,
Mann Whitney U test, Fisher’s exact test, or χ2 test where
appropriate. Logistic regression was used to identify risk fac-
tors predisposing to development of pericardial effusion. Vari-
ables as described above were entered into the multivariate
model. A probability value of p < 0.05 was considered signifi-
cant. All statistical analyses were performed using SPSS
version 10.0 (SPSS, Inc, Chicago, Illinois, USA).
RESULTS
Of the 359 patients recruited, 23 did not survive the cardiac
surgery. The remaining 336 patients (163 males) were
included in the final analysis, 102 (30%) of whom had
cyanotic congenital heart disease. Cardiac surgery was
performed at a median age of 1.7 years (range 1 day to 22.3
years) and a median weight of 10 kg (range 2.2–66 kg). The
operations performed were categorised into firstly, repair of
left to right shunts (n = 195); secondly, repair of lesions with
right ventricular outflow tract obstruction (tetralogy of Fallot
with or without pulmonary atresia, ventricular septal defect
with infundibular pulmonary stenosis) (n = 84); thirdly, arte-
rial switch operation for transposition of the great arteries
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(n = 15); fourthly, Fontan-type procedures (n = 10); and
fifthly, miscellaneous procedures including correction of
anomalous pulmonary venous drainage, prosthetic valve
replacement, repair of left ventricular outflow obstruction,
Ross procedure, and Norwood stage I operation (n = 32).
Seventy seven of the 336 (23%) patients developed pericar-
dial effusion postoperatively. The amount of effusion was
small in 34, moderate in 24, and large in 19 patients. The effu-
sion was already circumferential in 55 of 77 (71%) at first
presentation. Its onset was at 11 (7) days after surgery. Over-
all, the diagnosis was made on or before day 14 and day 28
after surgery in 79% (61 of 77) and 97% (75 of 77) of patients
who developed effusion, respectively. Importantly, 12% (4 of
34), 25% (6 of 24), and 32% (6 of 19) of patients with, respec-
tively, small, moderate, and large amounts of effusion
presented beyond the second week after operation (fig 1).
Clinical symptoms or signs were present in only 18 (23%)
patients. These were fever in 10 patients, gastrointestinal dis-
turbance such as vomiting or abdominal discomfort in two,
signs of fluid retention in three, irritability in two, and
evidence of tamponade in one. Patients who had a large
amount of effusion were more likely to be symptomatic than
those with only a small to moderate amount (47.4% v 15.5%,
p = 0.01). Likewise, patients with circumferential effusion
tended to be more symptomatic than those with loculated
effusion (29.7% v 9.0%, p = 0.077).
Conservative treatment with fluid restriction and diuretic
treatment in 44 (57%) patients with a small to moderate
amount of effusion resulted in resolution in all of these
patients. Anti-inflammatory medications were started in 21
patients (27%) who, albeit asymptomatic, had a moderate
amount of effusion with evidence of progression. Aspirin was
prescribed to seven patients and steroid was given to 14.
Eighteen patients responded, while three eventually required
pericardiocentesis. Pericardiocentesis, either by a surgical or a
percutaneous approach, as the initial treatment was per-
formed in 12 (16%) symptomatic patients with a large amount
of effusion. The median duration for effusion to resolve com-
pletely was eight days (range 1–394 days), with complete
resolution achieved in 83% (64 of 77) of patients within four
weeks of diagnosis.
Table 1 summarises the demographic, clinical, and peri-
operative variables of patients with and without pericardial
effusion. Significantly more female (28.9%) than male
(16.6%) patients developed pericardial effusion (p = 0.009),
with a relative risk of 2.05 (95% confidence interval (CI) 1.2 to
3.5). The prevalence of pericardial effusion after Fontan-type
procedures (60%) was significantly higher than that after
other types of surgery (p = 0.037) (fig 2). Furthermore, peri-
cardial effusions that developed after a Fontan-type proce-
dures were at least moderate to large. Postoperatively, a greater
pericardial drain output within the first four hours tended to
be associated with a higher risk of developing later effusion
(p = 0.056). Warfarin, given to 18 patients who had under-
gone valve replacement (n = 8), Fontan-type procedures
(n = 6), and patch repair of an atrial septal defect (n = 4),
also conferred a significant risk of developing a pericardial
effusion (relative risk 4.48, 95% CI 1.78 to 12.33, p = 0.002).
Logistic regression similarly identified sex (β for
male = −0.63, p = 0.037) and warfarin (β = 1.73, p = 0.009)
as significant determinants. Nonetheless, it is important to
note that in this cohort, warfarin was started in significantly
more female than male patients (8.7% v 1.8%, p = 0.007).
Furthermore, patients who had undergone arterial switch
operation, which had the lowest incidence of pericardial effu-
sion, were mostly male (73.3% v 26.7%, p = 0.068).
Figure 1 Cumulative percentage of patients who developed
pericardial effusion versus the time of onset.
Table 1 Comparisons of demographic, clinical, and perioperative variables between patients with and without






Median age (years) 2.3 1.7 0.60
Range 0.02–20.1 0–22.3
Weight (kg) 14.83 (13.8) 14.35 (12.9) 0.79
Sex (male:female) 27:50 136:123 0.009*
Cyanotic:acyanotic 24:53 78:181 0.89
Previous cardiac surgery 11 (14.3%) 38 (14.7%) 1.00
Types of operation
Left to right shunt repair 43/195 (22.1%) 152/195 (77.9%) 0.037*
RVOT surgery 19/84 (22.6%) 65/84 (77.4%)
Arterial switch operation 1/15 (6.7%) 14/15 (93.3%)
Fontan procedure 6/10 (60%) 4/10 (40%)
Miscellaneous 8/32 (25%) 24/32 (75%)
Reoperation for haemostasis 3 (3.9%) 3 (1.2%) 0.13
Pericardial drain removal (days post surgery) 2.2 (1.2) 2.1 (1.4) 0.36
Median first 4 hour total drain output (ml) 60 50 0.056
Range 15–1550 0–620
Median average hourly drain output on operation day (ml/h) 5.8 5.6 0.47
Range 2–101 0–57
Median average hourly drain output on day 1 postoperation (ml/h) 1.7 1.7 0.98
Range 0–21 0–11
Warfarin 10 (13%) 8 (3%) 0.002*
Diuretic 69 (90%) 210 (81%) 0.17
*Significant.
RVOT, right ventricular outflow tract.
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DISCUSSION
The prevalence of pericardial effusion after open heart surgery
has been reported to range from 53–85% in earlier studies.2–6
However, recent studies in both adults and children suggested
a decrease in prevalence. Yip and colleagues8 reported a 16%
prevalence in 339 adults undergoing surgical repair of atrial
septal defect, while Prabhu and associates7 reported a 13.6%
prevalence in 212 children and teenagers undergoing surgery
for congenital heart disease. Our study similarly shows, in a
large of cohort of patients, a relatively lower prevalence of
pericardial effusion, which has been attributed to improved
surgical and anaesthetic techniques, myocardial protection,
and improved postoperative haemodynamics.7 Additionally,
our study describes the evolution of the development of peri-
cardial effusion. While pericardial effusion can be detected
within the first two weeks of surgery in the majority (79%) of
patients, 21% of cases would have been missed if routine
echocardiographic screening had been confined to this time
period. Interestingly, our finding suggests that pericardial
effusion that eventually becomes moderate to large in amount
tends to present later.
Symptoms were present in only slightly more than a fifth of
our patients who developed pericardial effusion and these
symptoms were mostly non-specific. This is in contrast to the
findings of Clapp and colleagues,5 who reported that 16 of 21
children with postoperative effusion developed clinical evi-
dence of postpericardiotomy syndrome. The apparent discrep-
ancy may be because serial echocardiographic assessment
allows for early diagnosis and institution of anti-
inflammatory treatment before appearance of symptoms.
Nonetheless, the presence of symptoms may have important
implications, as symptomatic patients were more likely to
have a more severe degree of pericardial effusion and hence to
be at risk of haemodynamic compromise in the absence of
interventions. Close monitoring and early institution of
anti-inflammatory treatment are therefore warranted in
symptomatic patients.
Data on the efficacy of anti-inflammatory treatment for
postpericardiotomy syndrome in children are, however,
limited. While aspirin has been widely used, the reports were
largely anecdotal6 and, to date, there have been no controlled
trials on the efficacy of non-steroidal anti-inflammatory
agents. Prophylactic use of aspirin, on the other hand, has
been shown to have no significant benefit in the prevention of
postoperative pericardial effusion in children.6 In a double
blind placebo controlled trial of steroid in a small cohort of
children with postpericardiotomy syndrome, Wilson and
colleagues9 have shown that steroid hastens the remission in
the majority, although two of their 12 patients had a
further increase in the amount of effusion despite steroid
administration. Likewise, only three of our 21 (14%) patients
failed to respond to anti-inflammatory treatment. A trial of
anti-inflammatory treatment is hence justified in patients
with moderate and increasing amounts of pericardial
effusion before contemplation of the more invasive peri-
cardiocentesis.
To our knowledge, this is the first study to examine risk
factors predisposing to development of pericardial effusion
after open heart surgery for congenital heart disease. While
Prabhu and colleagues7 suggested a higher incidence of
effusion incidence after Ross procedure, the number of
patients included in their studied was too small to be
significant. We found that pericardial effusion occurred more
commonly after Fontan-type procedures. On the other hand,
infants, mostly boys, undergoing arterial switch operation for
transposition of the great arteries had the lowest incidence.
Similar to the findings of Stevenson and colleagues,3 a greater
pericardial drain output early postoperation tended to be
associated with an increased likelihood of pericardial effusion.
It has been proposed that the increased amount of blood
accumulated may irritate the pericardium through a hy-
drophilic action.10 11 Multivariate analysis showed that postop-
erative warfarin is a significant risk factor after adjustment of
other variables. This finding corroborates those reported in the
adult literature.2 12 13 Warfarin given routinely after Fontan-
type procedures probably explains in part the observed higher
incidence of pericardial effusion after this operation. The find-
ings that more of our patients taking warfarin were female
and that most undergoing arterial switch operation were male
may explain the significance of sex in determining the occur-
rence of pericardial effusion in this cohort. Interestingly, how-
ever, female adult patients have been shown to be at higher
risk for development of early postoperative cardiac tamponade
after open heart surgery in a recent study.14 While the
explanation remains unclear, female sex may indeed be an
independent risk factor, even after adjustment for confound-
ing influence.
On the basis of our findings, we recommend serial
echocardiography up to 28 days after open heart surgery for
congenital heart disease in selected at-risk patients, namely
those with symptoms suggestive of postpericardiotomy
syndrome and those receiving warfarin.
. . . . . . . . . . . . . . . . . . . . .
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A47 year old man with congenital heart block had a per-manent DDD pacemaker implanted at the age of 25years. Six months ago he had a battery change in the
right infraclavicular region, which was his seventh box
change. The pacemaker check recently undertaken showed
satisfactory pacemaker function. On the day of admission he
went to have a meal on his son’s birthday. As he was stretch-
ing his right arm to lift a heavy plate he had a funny sensation
in his right arm. Then he noticed that he felt very dizzy and
was about to pass out each time he abducted his right arm to
have a meal. He came to hospital with his right arm tightly
adducted to the chest wall.
A chest x ray revealed partial fracture in the ventricular lead,
hence it was losing electrical contact during arm abduction.
The patient was taken to the catheter laboratory and a new
ventricular lead and battery was implanted. This cured his
problem and he went home with an asymptomatic hand-
shake!
Lead fracture of a permanent pacemaker is a recognised
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IMAGES IN CARDIOLOGY.............................................................................
Femoral vein delivery of contrast improves transoesophageal detection of intracardiac shunting
through a patent foramen ovale
A33 year old woman on the oral contraceptive pill wasinvestigated after suffering a transient ischaemic attack.On transthoracic echocardiogram her interatrial septum
was mobile but not aneurysmal. On transoesophageal
echocardiography there was no clear anatomical evidence of a
septal defect or patent foramen ovale (PFO). Several agitated
saline contrast studies via the right cephalic vein failed to
show any evidence of an intracardiac shunt both with and
without a Valsalva manoeuvre (below left). This was then
repeated via a right femoral vein 5 French sheath and there
was notable and immediate passage of contrast into the left
atrium, even without a Valsalva manoeuvre (below right).
Paradoxical embolus via a PFO is a potential cause of
cerebrovascular events in a young patient. Diagnostic methods
include transthoracic and transoesophageal echocardiography
with colour Doppler and agitated saline contrast studies. Sen-
sitivity may be further enhanced by cough and the Valsalva
manoeuvre. Transcranial Doppler of the middle cerebral artery
may also be used. Inferior vena caval flow is preferentially
towards the interatrial septum and foramen ovale while the
crista interveniens directs superior vena cava flow away from
the interatrial septum. Thus, because of this “streaming”
effect, femoral vein delivery of agitated saline contrast may be
superior to the antecubital route for detection of transient
right to left shunting through a PFO.
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